Feasibility and Relevance of an Intervention with Systematic Screening as a Base for Individualized Rehabilitation in Breast Cancer Patients : A Pilot Trial of the ReScreen Randomized Controlled Trial
Olsson, Ing-Marie ; Malmström, Marlene LU
; Rydén, Lisa
LU
and Olsson Möller, Ulrika
LU
(2022)
In Journal of Multidisciplinary Healthcare
15.
p.1057-1068
- Abstract
Background: A substantial proportion of women with breast cancer (BC) experience a wide range of long-term persistent and troublesome side effects related to the disease and its treatment. The ReScreen randomized controlled trial is conducted aiming to evaluate the effect of early screening of distress followed by individualized rehabilitation after primary BC treatment.
Purpose: To examine recruitment, retention, distribution of distress, relevance of intervention and reported problems in a pilot trial of the ReScreen RCT.
Patients and methods: Based on international research, a cutoff of ≥7 on the Distress Thermometer was used to identify women in need of extended support. Those who reported high distress were randomized... (More)
Background: A substantial proportion of women with breast cancer (BC) experience a wide range of long-term persistent and troublesome side effects related to the disease and its treatment. The ReScreen randomized controlled trial is conducted aiming to evaluate the effect of early screening of distress followed by individualized rehabilitation after primary BC treatment.
Purpose: To examine recruitment, retention, distribution of distress, relevance of intervention and reported problems in a pilot trial of the ReScreen RCT.
Patients and methods: Based on international research, a cutoff of ≥7 on the Distress Thermometer was used to identify women in need of extended support. Those who reported high distress were randomized to intervention group (IG, n = 9) or control group (CG, n = 9), while women with low distress formed an observational group (OG, n = 67). Self-reported data was collected at baseline, 2 weeks and 3, 6, 9, and 12 months after start of treatment. The participants were recruited from a BC unit in Sweden. Descriptive statistics were used for analyses.
Results: Eighty-five patients consented to participate. The recruitment rate was 73%, answer frequency was 98%, 64%, 95%, and retention rate was 100%, 56%, 91% in the IG, CG and OG, respectively. Few systematic errors were identified. When exploring the distribution of distress, it was evident that the participants scoring ≥7 were fewer (21.2%) than reported in previous studies (34-43%). The most commonly problems reported were in line with previous reports of symptoms, including fatigue and worry.
Conclusion: The satisfactory rates of inclusion and data collection and the few systematic errors indicate that the ReScreen study is feasible if well planned and executed. To identify patients in need of extended support, an adjustment of the cutoff in the main study is indicated. Based on self-reported problems, the intervention was found relevant in this context.
(Less)
- author
- Olsson, Ing-Marie
; Malmström, Marlene
LU
; Rydén, Lisa
LU
and Olsson Möller, Ulrika
LU
- organization
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Multidisciplinary Healthcare
- volume
- 15
- pages
- 1057 - 1068
- publisher
- Dove Medical Press Ltd.
- external identifiers
-
- scopus:85130418612
- pmid:35586080
- ISSN
- 1178-2390
- DOI
- 10.2147/JMDH.S355055
- language
- English
- LU publication?
- yes
- additional info
- © 2022 Olsson et al.
- id
- 860d421b-c0b5-481e-898f-4779f3b2a563
- date added to LUP
- 2022-06-29 11:34:37
- date last changed
- 2024-06-25 02:50:03
@article{860d421b-c0b5-481e-898f-4779f3b2a563,
abstract = {{<p>Background: A substantial proportion of women with breast cancer (BC) experience a wide range of long-term persistent and troublesome side effects related to the disease and its treatment. The ReScreen randomized controlled trial is conducted aiming to evaluate the effect of early screening of distress followed by individualized rehabilitation after primary BC treatment.</p><p>Purpose: To examine recruitment, retention, distribution of distress, relevance of intervention and reported problems in a pilot trial of the ReScreen RCT.</p><p>Patients and methods: Based on international research, a cutoff of ≥7 on the Distress Thermometer was used to identify women in need of extended support. Those who reported high distress were randomized to intervention group (IG, n = 9) or control group (CG, n = 9), while women with low distress formed an observational group (OG, n = 67). Self-reported data was collected at baseline, 2 weeks and 3, 6, 9, and 12 months after start of treatment. The participants were recruited from a BC unit in Sweden. Descriptive statistics were used for analyses.</p><p>Results: Eighty-five patients consented to participate. The recruitment rate was 73%, answer frequency was 98%, 64%, 95%, and retention rate was 100%, 56%, 91% in the IG, CG and OG, respectively. Few systematic errors were identified. When exploring the distribution of distress, it was evident that the participants scoring ≥7 were fewer (21.2%) than reported in previous studies (34-43%). The most commonly problems reported were in line with previous reports of symptoms, including fatigue and worry.</p><p>Conclusion: The satisfactory rates of inclusion and data collection and the few systematic errors indicate that the ReScreen study is feasible if well planned and executed. To identify patients in need of extended support, an adjustment of the cutoff in the main study is indicated. Based on self-reported problems, the intervention was found relevant in this context.</p>}},
author = {{Olsson, Ing-Marie and Malmström, Marlene and Rydén, Lisa and Olsson Möller, Ulrika}},
issn = {{1178-2390}},
language = {{eng}},
pages = {{1057--1068}},
publisher = {{Dove Medical Press Ltd.}},
series = {{Journal of Multidisciplinary Healthcare}},
title = {{Feasibility and Relevance of an Intervention with Systematic Screening as a Base for Individualized Rehabilitation in Breast Cancer Patients : A Pilot Trial of the ReScreen Randomized Controlled Trial}},
url = {{http://dx.doi.org/10.2147/JMDH.S355055}},
doi = {{10.2147/JMDH.S355055}},
volume = {{15}},
year = {{2022}},
}